Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Assets (2016 - 2025)

Historic Return on Assets for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to 0.22%.

  • Niagen Bioscience's Return on Assets rose 1900.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.14% for FY2024, which is 2300.0% up from last year.
  • Niagen Bioscience's Return on Assets amounted to 0.22% in Q3 2025, which was up 1900.0% from 0.21% recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Return on Assets peaked at 0.22% during Q3 2025, and registered a low of 0.57% during Q2 2022.
  • Over the past 5 years, Niagen Bioscience's median Return on Assets value was 0.12% (recorded in 2023), while the average stood at 0.16%.
  • In the last 5 years, Niagen Bioscience's Return on Assets crashed by -500bps in 2022 and then skyrocketed by 4100bps in 2023.
  • Niagen Bioscience's Return on Assets (Quarter) stood at 0.46% in 2021, then rose by 18bps to 0.37% in 2022, then soared by 75bps to 0.09% in 2023, then soared by 248bps to 0.14% in 2024, then skyrocketed by 57bps to 0.22% in 2025.
  • Its Return on Assets stands at 0.22% for Q3 2025, versus 0.21% for Q2 2025 and 0.19% for Q1 2025.